Jazz Pharmaceuticals

FDA grants 'Priority Review' status to Jazz Pharmaceuticals' Xywav
FDA grants 'Priority Review' status to Jazz Pharmaceuticals' Xywav
Seeking Alpha
Jazz Pharmaceuticals
Flag link:
Jazz, in the hunt for new FDA nod, schools doctors on rare excessive sleepiness disorder
Jazz, in the hunt for new FDA nod, schools doctors on rare excessive sleepiness disorder
Fierce Pharma
Jazz Pharmaceuticals
FDA
idiopathic hypersomnia
Xywav
Flag link:
4 Pharma Stocks That Could Be Losers With the $1.9 Trillion Stimulus Package
4 Pharma Stocks That Could Be Losers With the $1.9 Trillion Stimulus Package
Motley Fool
stimulus
pharma stocks
Eli Lilly
Merck
Jazz Pharmaceuticals
AbbVie
Flag link:
Jazz CEO Bruce Cozadd campaigned for 6 months to buy GW Pharma. A 90% premium sealed the deal — along with $17.6M in ‘retention’ incentives
Jazz CEO Bruce Cozadd campaigned for 6 months to buy GW Pharma. A 90% premium sealed the deal — along with $17.6M in ‘retention’ incentives
Endpoints
Jazz Pharmaceuticals
Pharma CEOs
Justin Glover
GW Pharma
M&A
Flag link:
Pharma’s pipeline continues to provide drama as investors look beyond COVID in Q4
Pharma’s pipeline continues to provide drama as investors look beyond COVID in Q4
Pharmaforum
pharma industry
R&D
pandemic
earnings
COVID-19
Biogen
GW Pharma
Jazz Pharmaceuticals
GSK
Merck KGaA
Flag link:
JPM: Jazz eyes a 'dramatic' shift to new-drug revenue by 2022, CEO says
JPM: Jazz eyes a 'dramatic' shift to new-drug revenue by 2022, CEO says
Fierce Pharma
Jazz Pharmaceuticals
JPMHC 2021
Flag link:
Jazz launches new wave of marketing for Sunosi with TV ad and 50 new sales reps
Jazz launches new wave of marketing for Sunosi with TV ad and 50 new sales reps
Fierce Pharma
Jazz Pharmaceuticals
Sunosi
obstructive sleep apnea
television ads
Flag link:
Jazz's $1B SCLC drug fails combo trial, quashing hopes of quick full approval
Jazz's $1B SCLC drug fails combo trial, quashing hopes of quick full approval
Endpoints
Jazz Pharmaceuticals
lurbinectedin
small cell lung cancer
clinical trials
Flag link:
Jazz inks Redx pact to secure 2 targeted cancer therapies
Jazz inks Redx pact to secure 2 targeted cancer therapies
Fierce Biotech
Jazz Pharmaceuticals
Redx
cancer
targeted therapies
Flag link:
What's Behind Jazz Pharmaceuticals' Q2 Revenue and Earnings Beats
What's Behind Jazz Pharmaceuticals' Q2 Revenue and Earnings Beats
Motley Fool
Jazz Pharmaceuticals
earnings
Flag link:
Jazz Pharmaceuticals gets FDA OK for cataplexy drug as it prepares to replace old cash cow
Jazz Pharmaceuticals gets FDA OK for cataplexy drug as it prepares to replace old cash cow
Endpoints
Jazz Pharmaceuticals
Xywav
narcolepsy
cataplexy
FDA
Flag link:
Jazz preps first solid tumor launch with Zepzelca's small cell lung cancer nod
Jazz preps first solid tumor launch with Zepzelca's small cell lung cancer nod
Fierce Pharma
Jazz Pharmaceuticals
solid tumors
cancer
Zepzelca
drug launches
Flag link:
Why Jazz Pharmaceuticals Sang Off-Key in Q1
Why Jazz Pharmaceuticals Sang Off-Key in Q1
Motley Fool
Jazz Pharmaceuticals
earnings
Flag link:
Jazz Pharmaceuticals plc Beat Analyst Estimates: See What The Consensus Is Forecasting For Next Year
Jazz Pharmaceuticals plc Beat Analyst Estimates: See What The Consensus Is Forecasting For Next Year
Yahoo/Simply Wall St
Jazz Pharmaceuticals
earnings
Flag link:
Jazz targets US launch of SCLC drug after FDA grants fast review
Jazz targets US launch of SCLC drug after FDA grants fast review
Pharmaforum
PharmaMar
Jazz Pharmaceuticals
FDA
small cell lung cancer
lurbinectedin
priority review
Flag link:
Upcoming events – Avadel takes on Jazz and Axovant awaits early results
Upcoming events – Avadel takes on Jazz and Axovant awaits early results
EP Vantage
Avadel
FT218
Jazz Pharmaceuticals
Xyrem
Axovant
gene therapy
Parkinson's Disease
narcolepsy
Flag link:
Jazz Pharma Files for FDA Approval of a New Narcolepsy Drug
Jazz Pharma Files for FDA Approval of a New Narcolepsy Drug
Motley Fool
Jazz Pharmaceuticals
narcolepsy
JZP-258
FDA
Flag link:
Drug/Biotech Stocks Nov 5 Earnings Roster: AGN, REGN & More
Drug/Biotech Stocks Nov 5 Earnings Roster: AGN, REGN & More
Yahoo/Zacks.com
Allergan
Regeneron
Mylan
Catalent
Jazz Pharmaceuticals
Flag link:
Jazz Pharma Hits the Mark with Another Narcolepsy Treatment
Jazz Pharma Hits the Mark with Another Narcolepsy Treatment
BioSpace
Jazz Pharmaceuticals
narcolepsy
JZP-258
Flag link:
Biotechs Fly Sideways In Quiet Week — 5 News Items You May Have Missed
Biotechs Fly Sideways In Quiet Week — 5 News Items You May Have Missed
Investors Business Daily
Wave Life Sciences
suvodirsen
DMD
Merck
Keytruda
Biogen
Spinraza
Zoetis
Europe
animal health
Jazz Pharmaceuticals
JZP-258
narcolepsy
Flag link:

Pages